Evolving Systemic Treatments For Hepatocellular

Join Dr. Adam Burgoyne, an Associate Clinical Professor at the University of California, San Diego, and Dr. Stacey Stein, ...

The

Chair, Richard S. Finn, MD, Ahmed Omar Kaseb, MD, CMQ, and Stacey M. Stein, MD, discuss HCC in this CME/MOC activity titled ...

Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for

Host: Jacob Sands, MD Guest: Manish A. Shah, MD FASCO For patients with unresectable

Ghassan Abou-Alfa, MD, MBA, Memorial Sloan Kettering Cancer Center, New York, NY, discusses the potential utility of

A medical oncologist, a radiation oncologist, a hepatologist and a surgical oncologist discuss how recent developments are ...

Case Scenarios to Integrate Recent Progress There has been remarkable progress in the

Ghassan K. Abou-Alfa, MD, from the Memorial Sloan Kettering Cancer Center, discusses the

Practice-

Practice-

With new

In this week's VJOncology podcast, leading experts share the latest updates in the management of

Course Director, Riccardo Lencioni, MD, FSIR, EBIR, discusses

Richard S. Finn, MD, discusses his personal experience with regorafenib and nivolumab for his patients with

Join the Oncology Brothers, Drs. Rahul and Rohit Gosain, in this engaging podcast episode as they delve into the

Oliver Waidmann, MD, and Arndt Vogel, MD, discuss how the

Systemic Therapy

Video abstract of an original research "Effectiveness and Safety of

Course Director, Ghassan Abou-Alfa, MD, MBA, discusses advanced HCC management in this CME activity titled "New Options, ...